cordcell-cel. tronco do cordao umbilical

What cordcell-cel. tronco do cordao umbilical does

CordCell is Brazil's pioneer and market-leading private umbilical cord blood and tissue stem cell bank, founded in 2001 as the first company in the country to offer these services. Operating under the legal entity CryoHoldco do Brasil Instituto Medicina de Processamento e Armazenamento de Celulas Tronco S.A., the company collects, processes, cryopreserves, and stores hematopoietic stem cells from cord blood and mesenchymal stem cells from cord tissue at its laboratory in São Paulo with samples held in liquid nitrogen at -196°C. CordCell has served more than 20,000 Brazilian families and currently stores over 21,000 samples, with regulatory standing through AABB international certification and ANVISA RDC 836/2023 compliance.

The technology stack centers on certified laboratory processing (flow cytometry with 3 and 4 color cytometers for stem cell marker quantification), a controlled-rate automated gradual freezing process that cools samples to -80°C before transferring to liquid nitrogen vapor storage, and a modern biotechnology bunker in Barueri featuring 24/7 automated nitrogen level and temperature monitoring with backup generators and facial-recognition security access. Specialized biological material transport logistics move samples from hospitals and maternities nationwide to the São Paulo laboratory under temperature-controlled conditions. Salesforce is used as the CRM platform for customer data management.

The business model combines a one-time initial service package (covering pregnancy monitoring, collection, transport, laboratory testing, processing, and first-year storage) with recurring annual storage fees beginning in month 12. Free emergency transport to any transplant center in Brazil or worldwide is bundled at no additional cost. Go-to-market is sales-led through dedicated consultants engaging expectant families during pregnancy, supported by a nationwide network of trained nurses who perform collections at hospitals and maternities. Customer acquisition is driven primarily by obstetrician referrals, supplemented by direct-to-consumer channels including 0800 phone, WhatsApp, website, and organic social media. The primary customer segment is expectant Brazilian families seeking biological insurance against potential future disease.

Name

cordcell-cel. tronco do cordao umbilical

Legal name

CryoHoldco do Brasil Instituto Medicina de Processamento e Armazenamento de Celulas Tronco S.A.

Website

https://cordcell.com.br

Company type

Private

Founded year

2001

Operating status

Operating

Short description

CordCell is Brazil's pioneer private umbilical cord blood and tissue stem cell bank, founded in 2001, serving over 20,000 families with certified collection, laboratory processing, and cryogenic storage under AABB and ANVISA standards.

Ownership category

akta.pro rank

Product category

Stem Cell Banking

NAICS

Blood and Organ Banks (621991)

SIC

Services-Medical Laboratories (8071), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

akta.pro secondary industry

General Obstetrics (Prenatal/Antepartum Care) (HLAKAJAA)

Keywords

• Stem cell banking
• Cord blood storage
• Umbilical cord tissue
• Cryopreservation services
• Biotechnology storage

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Initial Service Package: One-time initial fee covering pregnancy monitoring, collection at hospital/maternity, specialized transport, laboratory testing and processing, and first year of cryogenic storage. Processing performed at certified laboratory with quality testing.
2. Annual Storage Maintenance: Recurring annual fee starting from the 12th month after birth for continued cryogenic storage of stem cell samples. Includes 24/7 monitoring and security.
3. Emergency Retrieval and Transport: When needed for medical use, CordCell covers the cost of sample retrieval from laboratory and transport in special temperature-controlled tanks to any transplant center in Brazil or worldwide at no additional charge to the family.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

CordCell collects, processes, and stores umbilical cord blood and tissue stem cells for expectant families across Brazil. Services span pregnancy monitoring, on-site collection at hospitals and maternities by trained nurses, laboratory processing via flow cytometry, controlled-rate cryogenic freezing and long-term storage at -196°C in liquid nitrogen vapor, and emergency transport of samples to any transplant center in Brazil or worldwide at no additional cost. The company holds AABB international certification and ANVISA RDC 836/2023 compliance.

Product overview

CordCell offers a comprehensive umbilical cord stem cell banking service encompassing the collection, laboratory processing, cryopreservation, and long-term storage of hematopoietic stem cells from cord blood and mesenchymal stem cells from cord tissue. The company provides two primary service tiers: (1) preservation of cord blood alone, and (2) preservation of cord blood plus cord tissue. These are supported by internal laboratory services including cell processing via flow cytometry, automated cryopreservation in liquid nitrogen at -196°C, and 24-hour monitored storage in a modern biotechnology facility in São Paulo. A complementary logistics service provides free transport of stored samples to any transplant center worldwide. The company operates as a full-service provider from pregnancy monitoring through to potential therapeutic use, maintaining over 21,000 stored samples with AABB-accredited quality standards.

Differentiator

Problem solved

Functional benefit

Products and services

• Preservação de Sangue do Cordão Umbilical (Umbilical Cord Blood Stem Cell Storage) Collection, processing, and cryopreservation of hematopoietic stem cells from umbilical cord blood for expectant families. Samples are stored in liquid nitrogen tanks at -196°C and may be used to treat more than 80 diseases including leukemias, lymphomas, anemias, and bone marrow failures.
• Preservação de Sangue + Tecido do Cordão Umbilical (Umbilical Cord Blood + Tissue Storage) Combined storage of hematopoietic stem cells from cord blood and mesenchymal stem cells from cord tissue for expectant families, providing a broader biological material portfolio for both standard cell therapies and regenerative medicine applications.
• Criopreservação e Armazenamento (Cryopreservation and Storage Service) Automated gradual freezing process (controlled-rate freezing to -80°C) followed by long-term storage in liquid nitrogen vapor at -196°C, with 24-hour automated monitoring, temperature sensors, nitrogen level sensors, backup generators, and facial-recognition security access controls at CordCell's biotechnology storage facility in Barueri.
• Transporte para Centro de Transplante (Sample Transport to Transplant Center) Free transportation of stored stem cell samples in temperature-controlled specialized tanks from CordCell's laboratory to any transplant center in Brazil or worldwide at no additional cost, when required for therapeutic use.

Quantifiable outcome

• More than 50,000 cord blood transplants performed worldwide
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• CryoHoldco do BrasilcoreOthers · 1 January 2001Parent company of CordCell. CryoHoldco do Brasil is the Instituto Medicina de Processamento e Armazenamento de Celulas Tronco S.A. Parent organization providing strategic direction and operational infrastructure for stem cell banking services.
• H.Hemo LaboratorycoreTechnology or IntegrationH.Hemo performs laboratory tests on collected biological samples. Both H.Hemo and CordCell's laboratory are certified by ANVISA and AABB, ensuring quality testing and processing standards.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Cryo-Cell International: One of the oldest and largest private family cord blood banks in the United States. Highly comparable to CordCell given its end-to-end cord blood and tissue banking model, recurring storage fees, and consumer-direct GTM supported by physician referrals.
• Cord Blood Registry (CBR): Among the world's largest private cord blood banks, offering collection, processing, and long-term cryogenic storage. Closely mirrors CordCell's service model, pricing tiers, and physician-referral-driven acquisition motion.
• ViaCord (Revvity/PerkinElmer): Established private cord blood and tissue banking service. Directly comparable to CordCell across product offering (cord blood + tissue), AABB-equivalent accreditation, and recurring storage revenue model.
• Cells4Life: UK-based private cord blood and tissue bank with multi-sample storage offerings. Comparable end-to-end service, cryopreservation technology, and recurring storage revenue structure.
• Smart Cells International: UK-headquartered private stem cell bank offering cord blood and tissue storage globally. Comparable business model, target customer (expectant families), and recurring subscription pricing.

Broad incumbents

• China Cord Blood Corporation: Largest operator of cord blood banks in China with a network of licensed facilities. Comparable core service of umbilical cord blood storage at scale and long-duration subscription revenue, though geographically distinct.
• FamiCord: European stem cell bank network offering private cord blood and tissue storage across multiple countries. Comparable end-to-end service portfolio and recurring revenue model, though operating at broader geographic scale.

Regional players

• CryoHoldco (Parent): Brazilian holding company that owns CordCell. Operates in the same regional market with adjacent stem-cell processing and storage services and could plausibly consolidate additional cord blood banking assets.
• Hemocord: Brazilian private cord blood and tissue bank. Directly comparable regional competitor offering similar collection, processing, and cryopreservation services within CordCell's home market.
• GeneCell: Brazilian private cord blood bank providing umbilical cord blood collection and storage. Competes head-to-head with CordCell in the same expectant-family segment across Brazil.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/cordcell_oficial
• LinkedInlinkedin.com/company/cordcell-biotecnologia

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about cordcell-cel. tronco do cordao umbilical